Xspray-logo-white
  • Home
  • About us
    • Business model
    • Our history – a timeline
    • Board of Directors & Board committees
    • Management
  • Technology
  • Pipeline
  • Media
  • Contact
  • Investors
  • en en
    • sv sv
  • Investors
    • Share information
      • Ownership structure
    • Financial calendar & Events
    • Financial reports
      • ESEF report
    • Prospectus
    • Press releases
    • Corporate governance
      • Corporate Structure
      • General meetings
      • Corporate Governance Reports
      • Nomination committee
      • Board of Directors & Board committees
      • Management
      • Accounting principles
      • Internal control & Risk management
      • Auditor
      • Articles of association
      • Remuneration

Press releases

All press releases Regulatory

Regulatory press release 2020-09-30

Number of shares and votes in Xspray

Regulatory press release 2020-09-25

Xspray announces positive preliminary results from the study for its lead product candidate HyNap-Dasa

Regulatory press release 2020-09-21

Michael Wolff Jensen will not stand for re-election as Chairman of Xspray Pharma AB

Regulatory press release 2020-08-31

Number of shares and votes in Xspray

Press release 2020-08-31

Xspray announces positive stability data on HyNap-Dasa tablets

Regulatory press release 2020-08-21

Warrant holders exercise all warrants within the framework of incentive program

Regulatory press release 2020-08-18

Xspray strengthens the value of the product portfolio with patent protection for tablet of dasatinib propylene glycol solvate

Regulatory press release 2020-08-12

Xspray announces preliminary results from the first study for its lead product candidate HyNap-Dasa

Press release 2020-08-03

Xspray enters manufacturing collaboration in Malta

Regulatory press release 2020-07-31

Xspray Pharma publishes Interim Report Q2, January – June 2020

Show more

IR contact

Kerstin Hasselgren, IRO / Senior Adviser

+46 (0)70 311 16 83

info@xspray.com

Subscribe

  • Submit to our press releases and get an email every time we publish a press release or report on our website.
  • When clicked on Send I agree that my personal information will be saved. Read more
  • This field is for validation purposes and should be left unchanged.
Xspray-logo-white

Xspray Pharma AB Scheeles väg 2 171 65 Solna

+46 (0)8 730 37 00 info@xspraypharma.com

We use cookie to give you the best experience of our site. If you continue to use this website we will assume you agree. Read more about our Privacy policy.I agree